MINERALCORTICOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF ENDOMETRIOSIS

The present invention provides the use of mineralocorticoid receptor antagonists for preparing a medicament for the treatment of endometriosis. The present invention relates in particular to an improved therapeutic composition for endometriosis which has a more favorable activity and side-effect pro...

Full description

Saved in:
Bibliographic Details
Main Authors MOELLER CARSTEN, KAUFMANN-REICHE ULRIKE, SCHMIDT ANJA, FISCHER OLIVER-MARTIN, FUHRMANN ULRIKE
Format Patent
LanguageEnglish
Published 06.01.2011
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention provides the use of mineralocorticoid receptor antagonists for preparing a medicament for the treatment of endometriosis. The present invention relates in particular to an improved therapeutic composition for endometriosis which has a more favorable activity and side-effect profile than treatment therapies currently available. Using a mineralocorticoid receptor antagonist, it is possible to threat endometriosis permanently without any loss of bone mass.
Bibliography:Application Number: US20080529447